These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 22377746

  • 21. Population pharmacokinetics and bioavailability of tacrolimus in kidney transplant patients.
    Antignac M, Barrou B, Farinotti R, Lechat P, Urien S.
    Br J Clin Pharmacol; 2007 Dec; 64(6):750-7. PubMed ID: 17425625
    [Abstract] [Full Text] [Related]

  • 22. Population pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantation.
    Yang JW, Liao SS, Zhu LQ, Zhao Y, Zhang Y, Sun XY, Rao W, Qu W, Li WZ, Sun LY.
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):75-83. PubMed ID: 25207550
    [Abstract] [Full Text] [Related]

  • 23. Clinical pharmacokinetics of oral versus sublingual administration of tacrolimus in adult liver transplant recipients.
    Nasiri-Toosi Z, Dashti-Khavidaki S, Nasiri-Toosi M, Khalili H, Jafarian A, Irajian H, Abdollahi A, Sadrai S.
    Exp Clin Transplant; 2012 Dec; 10(6):586-91. PubMed ID: 22770208
    [Abstract] [Full Text] [Related]

  • 24. Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants.
    Staatz CE, Taylor PJ, Lynch SV, Willis C, Charles BG, Tett SE.
    Transplantation; 2001 Sep 27; 72(6):1056-61. PubMed ID: 11579300
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Population pharmacokinetics of cyclosporine in clinical renal transplant patients.
    Wu KH, Cui YM, Guo JF, Zhou Y, Zhai SD, Cui FD, Lu W.
    Drug Metab Dispos; 2005 Sep 27; 33(9):1268-75. PubMed ID: 15932953
    [Abstract] [Full Text] [Related]

  • 30. Relationship among changes in hematocrit, albumin and corticosteroid dose on the disposition of tacrolimus during the first six months following renal transplantation.
    Robles-Piedras AL, Romano-Moreno S, Fuentes-Noriega I, Mancilla-Urrea E, González-López EH, Domínguez-Ramírez A.
    Proc West Pharmacol Soc; 2011 Sep 27; 54():30-2. PubMed ID: 22423577
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Impact of body composition on pharmacokinetics of tacrolimus in liver transplantation recipients.
    Chen L, Lu X, Tan G, Zhu L, Liu Y, Li M.
    Xenobiotica; 2020 Feb 27; 50(2):186-191. PubMed ID: 30995884
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance.
    Antignac M, Hulot JS, Boleslawski E, Hannoun L, Touitou Y, Farinotti R, Lechat P, Urien S.
    Eur J Clin Pharmacol; 2005 Jul 27; 61(5-6):409-16. PubMed ID: 15991041
    [Abstract] [Full Text] [Related]

  • 36. Population pharmacokinetic analysis of tacrolimus in Chinese cardiac transplant recipients.
    Gong Y, Yang M, Sun Y, Li J, Lu Y, Li X.
    Eur J Hosp Pharm; 2020 Mar 27; 27(e1):e12-e18. PubMed ID: 32296499
    [Abstract] [Full Text] [Related]

  • 37. Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients.
    Sam WJ, Aw M, Quak SH, Lim SM, Charles BG, Chan SY, Ho PC.
    Br J Clin Pharmacol; 2000 Dec 27; 50(6):531-41. PubMed ID: 11136292
    [Abstract] [Full Text] [Related]

  • 38. Prospective evaluation of the bayesian method for individualizing tacrolimus dose early after living-donor liver transplantation.
    Fukudo M, Yano I, Shinsako K, Katsura T, Takada Y, Uemoto S, Inui K.
    J Clin Pharmacol; 2009 Jul 27; 49(7):789-97. PubMed ID: 19487492
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors.
    Guo F, Letrent SP, Sharma A.
    Cancer Chemother Pharmacol; 2007 Nov 27; 60(6):799-809. PubMed ID: 17285315
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.